V5A (p.Val5Ala) variant of B2M (Beta-2-microglobulin)
V5A (p.Val5Ala) in B2M (Beta-2-microglobulin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
V5A (p.Val5Ala) variant details
- p.Val5Ala
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available